Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |